Overview
ACET market data
Price History
ACET price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$1.33 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.61 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -93.2% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $6.01 – $17.44 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $75.9M · P/B 0.51 · P/S 1.96.
Company News
Guggenheim Maintains Buy on Adicet Bio, Lowers Price Target to $90Benzinga · Aug 6, 2026, 1:51 PM
Adicet Bio Q2 EPS $(1.99) Beats $(2.03) EstimateBenzinga · Aug 5, 2026, 10:08 PM
Lupus Nephritis Clinical Trial Landscape Becomes Increasingly Crowded with 30+ Pharma Companies | DelveInsightGlobenewswire Inc · Jun 10, 2026, 5:15 PM